Skip to main content
European Respiratory Review logoLink to European Respiratory Review
. 2012 Jun;21(124):112–124. doi: 10.1183/09059180.00005111

Primary prevention: exposure reduction, skin exposure and respiratory protection

Dick Heederik *,, Paul K Henneberger #, Carrie A Redlich , on behalf of the ERS Task Force on the Management of Work-related Asthma
PMCID: PMC9487304  PMID: 22654083

Abstract

Interventions for the primary prevention of occupational asthma have been reported in the medical literature, understanding the effectiveness of these efforts could help future interventions.

The aim of our study was to evaluate the existing knowledge regarding the impact of controlling work exposure on the prevention of occupational asthma. We conducted systematic literature searches through April 2010 to examine if control of workplace exposures is effective for primary prevention of sensitisation and occupational asthma.

The literature search for primary prevention of occupational asthma yielded 29 studies. Assessment of the available information led to the following conclusions and recommendations concerning primary prevention of occupational asthma. Exposure elimination is the strongest and preferred primary preventive approach to reduce the burden of occupational asthma. If elimination is not possible, exposure reduction is the second best option for primary prevention of occupational asthma.

The evidence for the effectiveness of respirators in preventing occupational asthma is limited, and other options higher in the list of controls for occupational exposures, notably eliminating or minimising exposures at the source or in the environment, should be used preferentially. There is strong evidence to recommend not using powdered allergen-rich natural rubber latex gloves. There is weak evidence that suggests workers should minimise skin exposure to asthma-inducing agents.

Keywords: Asthma, exposure reduction, occupational asthma, primary prevention, respiratory protection


Primary prevention of occupational asthma involves reducing exposure so that susceptible workers do not develop disease. In practice, the prevention of occupational asthma is often challenging, but still attainable. Control of exposure can be achieved by different control measures and a hierarchical strategy is commonly applied (table 1). The preferred measure is substitution of an agent, for instance, substitution of enzymes with strong sensitising potential by less strong sensitising enzymes, or a change to a process that does not require the use of enzymes at all. When substitution is not possible, exposure reduction is the next best approach. Exposure reduction can be achieved by reducing the source strength (i.e. amount or concentration emitted), modifying the formulation of the active ingredient (e.g. liquid or granule instead of powder), changing the process, or by improving general hygiene (good housekeeping). Other options are isolation of the source (enclosure or segregation), ventilation, avoidance of exposure, and use of personal protective equipment (PPE). Often, optimal exposure reduction strategies consist of a combination of technical and organisational measures. In practice, exposure reduction relies on a combination of different interventions. Latex is an exceptional example, where considerable exposure reduction is achieved by using non-powdered instead of powdered gloves.

Table 1. Hierarchy of control measures for airborne contaminants in the work environment in order of priority (top to bottom) and in order of preference (left to right).

Control measure Agent Process/appliance Working environment Work practice
Elimination Total substitution Different process Layout change Automation, robotisation, remote control
Reduction Partial substitution, change of form Adjustment,
preventive maintenance, specialised appliance
Good housekeeping Correct work procedures, training, instruction, motivation, supervision
Isolation Enclosure segregation Glove box, safety cabinet, segregation, high-exposure departments Ensuring enclosure
Ventilation Local exhaust ventilation, push/pull ventilation Dilution ventilation, air douches, air curtains Portable jets, low-volume, high-velocity tools
Exposure avoidance Booths for operators Shorter shifts, fewer people, work schedules
Personal protection Respiratory protection, gloves, clothing

It is important to define a desirable exposure reduction, and exposure standards can play an important role in this process. Exposure standards proposed by the European Union Scientific Committee on Occupational Exposure Limits are legally binding for all Union member states or national standard setting bodies. These standards are based on generally accepted and transparent risk assessment principles. Professional organisations in Europe and the USA may also recommend exposure standards. However, few standards exist for allergens [1], and these standards may not always protect workers against development of disease.

WHAT EVIDENCE IS AVAILABLE ON THE EFFECT OF PREVENTION?

There are different levels of evidence on the effect of preventative measures in the work environment. While the effect of generic exposure control measures has been evaluated under experimental conditions, this will not be discussed further. A review on efficiency and efficacy is available [2], which describes the development and evaluation of an evidence database on the effectiveness of risk management measures to control inhalation exposure. There is some evidence for the effect of individual control measures on allergen exposure. Control measures have been studied in cross-sectional studies in which determinants of exposure are explored by comparing situations with and without the specific determinant. Fewer studies make use of before and after comparisons in which the effect of a control measure on exposure is followed over time. Optimally, the effect of control measures should be evaluated using randomised trials or crossover designs, as was attempted in a study on wood dust exposure in the state of Minnesota in the USA, in which 48 businesses were randomised to an intervention (written recommendations, technical assistance and worker training) or comparison (written recommendations alone) condition. The Minnesota Wood Dust Study exemplifies the complexity of primary intervention in the work environment, which should not be compared with clinical interventions [3, 4].

First, companies are heterogeneous with regard to industrial processes and, as a result, different approaches can or have to be chosen to realise similar exposure reductions. This makes the intervention process difficult to control. Interventions in the work environment are, therefore, usually referred to as pragmatic interventions.

Secondly, prevention interventions with the health effect as the critical end-point may ethically be difficult to defend, especially when the result can only be measured after several years of intervention. Withholding interventions from workers can create complex legal and ethical situations for physicians and researchers, as well as employers. Therefore, it makes more sense to intervene on the exposure, and use the exposure level as the outcome of interest. Health impact assessments may help define the intervention goals [5].

These points illustrate why the number of intervention studies based on randomised trials or even well-designed cohort or case–control studies is limited. Most interventions have been evaluated by exploring time trends for occupational allergy or asthma cases using disease registry data. This approach has the limitation that, while the number of cases might be accurate, the denominator (i.e. the population at risk from which the cases arise) is not well defined and may change over time.

From key question 5 in the guidelines on the management of work-related asthma [6], “What is the impact of controlling work-related exposures to prevent asthma?”, three sub-questions guided the review of existing literature on the primary prevention of occupational asthma.

5a) Is elimination or reduction of workplace exposures to allergens and irritants effective for primary prevention of occupational sensitisation and asthma? 5b) What is the effectiveness of reducing skin exposures to prevent occupational asthma? 5c) What is the effectiveness of PPE (masks, respirators and gloves) to prevent occupational sensitisation and asthma?

METHODS

The statements and recommendations formulated in this review are based on a systematic evaluation of the international literature according to the methods extensively described by Baur et al. [6].

Search results as well as a list of considered articles were included in evidence tables and are presented in table O3 of the online supplementary material in the article by Baur et al. [6].

RESULTS

The search, initially performed in June 2008, yielded 72 results. An updated search was performed in April 2010 and yielded six additional results, thus the final yield of our search was 78 references. The identified references were selected on the basis of the abstracts. This resulted in 16 remaining references described in the evidence tables. The literature search strategy for skin references yielded 44 results, but no references that specifically addressed the impact of reducing skin exposure. Abstracts for these 44 references were reviewed and 15 references were identified in which researchers evaluated skin exposure in workers at risk of developing occupational asthma or relevant review articles addressing occupational skin exposure and asthma. Additional references in this section were identified from articles cited by the selected articles.

The literature search for PPE yielded 77 results. We reviewed abstracts for the 77 references and identified 14 in which researchers tested respirators that were intended to control exposure to occupational asthma agents. One reference was excluded after review of the full text article revealed it was not appropriate. The remaining 13 articles were the basis for the text on the effectiveness of respirators for primary prevention.

Is elimination or reduction of workplace exposures to allergens and irritants effective for primary prevention of occupational sensitisation and asthma?

Exposure response studies

Numerous studies, mostly cross-sectional in nature, have examined relationships between exposure to allergens and the occurrence of sensitisation or work-related asthma. Exposure response studies support the concept that exposure reduction is likely to be followed by a reduction in disease burden. A positive dose–response relationship between exposure and sensitisation has been found in both experimental animal studies [7] and studies of workers exposed to allergens of high molecular weight (HMW) and low molecular weight, including wheat flour, fungal α-amylase, laboratory animal allergens, organic acid anhydrides, isocyanates and platinum salts [820]. Some of these studies use variables known or likely to be associated with exposure level, such as duration of exposure or number of hours exposed per week. Others make use of more elaborate exposure assessment strategies, in which the exposure has been monitored by personal or area sampling equipment, followed by analysis of the allergen content of the dust sample. The latter approach facilitates the description of a quantitative exposure response relationship between measured exposure level and occurrence of sensitisation or asthma. Exposure response relationships indicate that implementation of primary preventive measures in the workplace that result in a reduction of exposure should also lead to a reduction in sensitisation rate.

Exposure reduction studies

What observations indicate that certain preventive measures lead to a reduction of exposure? The effect of few exposure reduction measures has been studied in practice. Thus, little is known about the effectiveness and efficacy of many possible exposure reduction measures. Studies have explored the effect on exposure of work tasks, cleaning and protective procedures, quality of ventilation systems and work routines in a range of different settings, such as bakeries [2123], wood industries [2427] and hairdressers [28]. However, these studies are usually cross-sectional and more exploratory in nature.

Natural rubber latex

Stronger evidence is shown in table 2, stratified by specific allergen. The most convincing example of the beneficial effects of an intervention is exposure to latex allergens. For latex, a meta-analysis is available that includes the separate studies described in table 2 [29]. Several studies explored differences in exposure levels between healthcare workers using powdered and non-powdered gloves. The most powerful study investigating the use of non-powdered gloves, which was associated with lower exposure, was a longitudinal case crossover intervention. In this study, introduction of powder-free, protein-poor natural rubber latex (NRL) gloves led to 10-fold lower aeroallergen exposure levels [31]. The effect of this single preventive measure on the prevalence or incidence of sensitisation and occupational asthma has been studied for NRL as well. A review of the literature in 2006 indicated that eight primary prevention intervention studies had been published on NRL exposure since 1990 [29], including the exposure study described previously [31]. All the studies in this review that explored disease as the outcome were observational studies that showed a decrease in sensitisation rates, either in a cross-sectional analysis or in a longitudinal design (both prospective and retrospective) [32, 3436, 39]. These studies on latex form the largest evidence base of primary prevention studies for any occupational asthma. This study concluded that substitution of powdered latex gloves with low-protein, powder-free NRL gloves or latex-free gloves greatly reduces NRL aeroallergens, NRL sensitisation and NRL asthma in healthcare workers. None of the individual studies fulfilled strict criteria for good-quality intervention studies, i.e. they were observational studies without a randomised design. However, taken together, these studies support assertions that substitution of NRL greatly reduces NRL sensitisation and asthma. The studies evaluated as evidence in support of this statement were ranked Scottish Intercollegiate Guidelines Network (SIGN) level 2+, meaning they were well-conducted, case–control or cohort studies with a low risk of confounding, bias or chance, and a moderate probability that the relationship is causal.

Table 2. Key question 5a: evidence for prevention of asthma due to natural rubber latex (NRL).
First author [ref.] Main conclusion Origin SIGN grade Study type Exposure/occupation Subjects
LaMontagne [29] Substitution of powdered latex gloves with low-protein powder-free NRL gloves or latex-free gloves greatly reduces NRL aeroallergens, NRL sensitisation, and NRL asthma in healthcare workers Literature search 1+ Systematic review NRL exposure Eight studies ranging from exposure studies and observational data from cohort studies
Allmers [30] Decreased use of powdered gloves and increased use of powder-free gloves correlated with decline in suspected NRL occupational asthma and skin allergy cases, 1997–2001
Conclusion: primary prevention of occupational NRL allergies is possible with properly implemented practical interventions
LaMontagne [29] 3 Case series, reported number of suspected NRL allergy cases from German healthcare system NRL exposure from gloves 3 million insured healthcare workers in Germany
Heilman [31] Latex aeroallergen levels and extractable latex glove allergen contents in an operating room measured on 52 consecutive days, including 19 non-surgery days, with 12 exposure crossovers
On 33 surgery days, all personnel wore either high-allergen gloves (n=18 days) or low-allergen gloves (n=15 days)
Internal comparison (cross-over)
Conclusion: substitution of low-allergen NRL gloves for high-allergen NRL gloves can reduce latex aeroallergen levels by more than 10-fold in an operating room environment
LaMontagne [29] 2++ (cross-over design like RCT) Prospective evaluation of an intervention Operating room personnel exposed to NRL Measurements on 52 days
Jones [32] Studied dental students from first to final year in training
Students used only powder-free NRL gloves and were tested annually
Students were 65% atopic, but none developed latex sensitivity in 5 yrs of study
Conclusion: exposure to powder-free NRL gloves was not associated with sensitisation over 5 yrs in a highly atopic population
LaMontagne [29] 2+ Prospective evaluation of intervention NRL exposure in dental students 63 dental students at baseline, 34 at final year (loss to follow-up)
Lee [33] Education to reduce NRL glove use in food handlers, use was reduced from 10 stalls to one
Conclusion: educate food handlers to prevent NRL allergy in workers and customers
LaMontagne [29] 3 Intervention among food handlers in Australia NRL glove use in food handlers 30 food stalls at market
Levy [34] Final year dental students in Paris, France and London, UK completed a questionnaire and SPT with NRL extract
Latex sensitivity was OR 11.3 (95% CI 2.4–53.0) for using protein-rich gloves
Conclusion: use of powder-free protein poor NRL gloves may reduce latex sensitisation
LaMontagne [29] 2- Cross-sectional study: some students used protein-rich gloves and others did not Use of protein-rich versus protein- poor NRL gloves in dental clinic 189 fifth year (graduating) dental students working in clinics
Liss [35] In 1996, the Ontario government recommended change to powder-free, low-protein or non-NRL gloves in healthcare, and hospitals changed related policies at the same time
Researchers documented a decline in worker compensation claims for NRL occupational asthma, from 7–11 per yr in 1991–1994 to 1–2 per yr in 1997–1999
Conclusion: use of low-protein or non-NRL gloves is associated with a decrease in number of NRL occupational asthma cases
LaMontagne [29] 3 Case series based on workers' compensation claims in Ontario province, Canada Use of powdered NRL gloves and change to low-powder NRL and non-NRL gloves in healthcare facilities 66 workers' compensation claims for NRL through 1999
Saary [36] and Tarlo [37] Dental school in Ontario province, Canada, changed from high-protein/powdered to low-protein/non-powdered NRL gloves
A positive NRL SPT in students decreased from 10% in 1995 to 3% in 2000 (p=0.03)
There was a decline in per cent with urticaria, immediate pruritis and rhino-conjunctivitis, but not asthma or eczema
Conclusion: suggestive preventive effect by change to low-protein/powder-free NRL gloves in dental school
LaMontagne [29] 2- Intervention for students and staff in dental school, between cross-sectional surveys in 1995 and 2000 (two different study cohorts) NRL gloves in dental school 131 in 1995 and 97 in 2000
Liss [35] and Tarlo [38] Study conducted in teaching hospital in Ontario, Canada
Intervention was education and medical surveillance, and change to powder-free NRL gloves
Decline in symptom onsets and clinic visits after change in non-sterile gloves in 1995 and sterile gloves in 1997, to final year of study in 1999
Conclusion: NRL allergy reduced
LaMontagne [29] 3 Intervention and retrospective record review to detect NRL allergy cases in occupational health and allergy clinics NRL in gloves in hospital 8000 employees, 52 staff with positive skin test responses and clinical NRL allergy

SIGN: Scottish Intercollegiate Guidelines Network; RCT: randomised controlled trial; SPT: skin-prick test.

Other asthma-inducing agents

Fewer studies are available for asthma-inducing agents other than NRL. One example of a longitudinal exposure study is the study by Meijster et al. [40], which explored the effect of control measures on dust and allergen exposure in a nonrandomised design. The authors found that changes in exposure over time varied substantially between sectors and jobs. For bakeries a modest downward annual trend in exposure of -2% was found for flour dust and -8% for fungal amylase. For flour mills the annual trend for flour dust was -12%, while no significant trend was observed for amylase. For ingredient producers, results were generally nonsignificant but indicated a reduction in flour dust exposure and increase in fungal α-amylase exposure. A modest increase in use of control measures and proper work practices was reported in most sectors, especially the use of local exhaust ventilation and decreased use of compressed air. Few longitudinal studies like this one have been performed and most studies have not used experimental designs.

In other environments, studies have been undertaken with interventions comprising combinations of different preventive dust control measures, as well as education and PPE. During a 10-yr follow-up, Smith [41] found a decrease in the annual incidence rates of symptomatic sensitisation to flour and fungal amylase in bakers from 2,085 per million to 405 per million employees per year (table 3). The intervention focused on information and training, installation of local exhaust ventilation, and wearing of respirators during handling of powdered bread improvers. No exposure data was included. Dissemination of information about exposure limits of diisocyanates to public (health) authorities in Ontario, Canada, together with a primary preventive programme and health surveillance, probably resulted in lower exposure levels and a decrease in accepted claims over time. Tarlo et al. [43] retrospectively assessed workers compensation data from 1980 to 1993 and found an initial increase in compensation claims, which were attributed to increased case findings due to the medical surveillance programme. The subsequent 50% decrease in accepted claims from 1991 to 1992–1993 was attributed to a combination of primary and secondary prevention measures. When measured levels of diisocyanate were compared among companies who had compensated claims for occupational asthma with companies without accepted claims, the former were more likely to have had measured levels of diisocyanates >0.005 ppm [43].

Table 3. Key question 5a: evidence for prevention of asthma due to a variety of agents.
Main conclusion Origin SIGN grade Study type Exposure/occupation Subjects
Anhydrides
    Grammer [42] Before introduction of respirators, annual incidence for asthma was 10%
In 7 yrs of follow-up after respirators, highest annual incidence was 2%
Conclusion: respirators can reduce incidence of occupational asthma, in workers exposed to HHPA
Literature search 2+ Prospective cohort study following intervention (introduction of respirators) HHPA 66 new workers who made HHPA
Diisocyanates
    Tarlo [43] In 1983, Ontario, Canada mandated medical surveillance programme for workers exposed to diisocyanates, followed by retrospective assessments to determine benefits
Frequency of diisocyanate asthma workers' compensation claims (both number and percentage of all occupational asthma claims) peaked in 1988, and then declined in 1993
Conclusion: medical surveillance programme contributed to the positive change, but reduced diisocyanate exposures and increased awareness of problem by workers and physicians may have also contributed to decline
Literature search 3 for surveillance and 2+ for case–control study within case series Registry based ecological study
Case series from workers' compensation claims for occupational asthma attributed to diisocyanates in province of Ontario, Canada
Diisocyanate exposure (study had exposure above threshold limit value as readout parameter) Number of claims varied by year, from 55–58 claims per yr in 1988–1990, to 19–20 claims per yr in 1992–1993
Flour and other bakery exposure
    Smith [41] The intervention reduced bread improver levels by better exhaust ventilation, respiratory protection, education, respiratory health surveillance and dust sampling
There was an overall reduction in the incidence of new cases of symptomatic sensitisation, from 2085 per million employees per yr in the first 5 yrs of the surveillance programme, to 405 per million employees per yr in the subsequent 5 yrs
Symptomatic sensitisation incidence was not related to total inhalable dust levels
Conclusion: the strategy of targeting bread improver exposure is an effective approach for preventing symptomatic sensitisation in bread bakeries
Literature search 2- Prospective intervention in UK food company
Based on surveillance data in combination with a triage approach that was not validated
Bakery workers, flour millers exposed to flour and enzymes, especially fungal amylase >3000 workers per year under surveillance
    Meijster [40] Changes in exposure over time varied between sectors and jobs
For bakeries: modest downward trend of -2% per yr for flour dust and -8% per yr for amylase
For flourmills: -12% per yr for flour dust and no significant trend for amylase
For ingredient producers: results generally nonsignificant, but indicated a reduction in flour dust and increase in fungal α-amylase
Modest increase in use of control measures and proper work practices reported in most sectors, especially local exhaust ventilation and decreased use of compressed air
Conclusion: the magnitude of the observed reductions in exposure levels indicates that the sector-wide intervention strategy implemented had a limited overall effect
Literature search 2+ Sector-wide intervention programme, with education on good work practices, and nonrandomised before and after evaluation of exposure to wheat and fungal α-amylase Bakery workers, flour millers, bakery ingredient workers 1770 personal exposure measurements generally including data on flour dust and fungal α-amylase levels, taken in four surveys (1993, 2001, 2005 and 2007)
Detergent enzymes
    Cathcart [44] At five production facilities in the UK dust and enzymes levels in 1969–1993, lung function of workers in 1972–1991, and cases of occupational asthma in 1968–1992 were evaluated
Exposure groups were defined by job history
Enzyme levels declined over the study period
Changes in FEV1 and FVC showed no consistent trends in relation to enzyme exposure
The annual number of cases of enzyme allergy and asthma declined
Literature search 2- Registry-based study, case series, ecological Detergent enzyme exposure in production facilities 731 male workers
    Schweigert [45] Variety of controls introduced across detergent enzyme manufacturing industry
Decrease in number of occupational asthma cases in Latin American and North American detergent enzyme manufacturing sites in 1969–1998, but no denominators indicated
Literature search 4 Review article with minimal data and documentation Detergent enzyme manufacturing industry Unclear
Laboratory animal allergy and asthma
    Botham [46] Prospectively studied incidence of allergy to laboratory animals in 383 workers exposed to rodents and to rabbits
Intervention was introduction of a site order and code of practice for working with animals, and an education programme
Concurrent with the intervention, incidence of allergy after 1 yr of exposure to animals fell from 37% in 1980–1981 to 20% in 1982, 10% in 1983 and 12% in 1984
Atopy increased risk of allergy in first year of exposure but not in second or third years of exposure
Literature search 2- Intervention study with longitudinal, repeated measurements Laboratory animal workers with exposure to rodents and rabbits 383 workers
    Fisher [47] Intervention programme included education, engineering controls, administrative controls, use of personal protective equipment, and medical surveillance
Prospective survey of 5 yrs of data to determine effect programme (1991–1995)
At the start of the programme, prevalence of laboratory animal allergy was 12–22%, and then 0% in the last 2 yrs of the 5-yr observation period
Conclusion: laboratory animal allergy is preventable through the implementation of a comprehensive effort to reduce exposure to allergens
Literature search 2- Comprehensive intervention programme with longitudinal, repeated measurements Laboratory animal workers 159 employees

SIGN: Scottish Intercollegiate Guidelines Network; HHPA: hexahydrophthalic anhydride; FEV1: forced expiratory volume in 1 s; FVC: forced vital capacity.

In the detergent industry, the introduction of work practices and a medical surveillance programme decreased sensitisation rates to enzymes among workers within almost 20 yrs [45]. Significant reductions in the prevalence of occupational asthma have been reported after introducing granulated proteases [44, 48]. In the study of Cathcart et al. [44], during the observation period, atmospheric enzyme concentrations and the reported incidence of enzyme asthma fell considerably. However, the number of cases dropped, but the denominator, consisting of the number of individuals at risk, was not established. So, it is unclear if the risk for an individual declined. It cannot be excluded that the number of workers exposed declined over the years because of mechanisation and automation of production processes. Cullinan et al. [49] reported an outbreak of asthma in a detergent factory which exclusively used encapsulated enzymes, while sensitisation rate was related to exposure level. A recent study showed a similar outbreak but in an enzyme factory using liquid enzyme formulations [50].

In laboratory animal workers allergy, a preventative programme including education, engineering and administrative controls, the use of respirators and medical surveillance showed a decrease in the incidence rate of asthma from 10% to 0% during a 5-yr follow-up [47]. However, this study was not designed as a cohort study, there was considerable loss to follow-up and forms of selection bias such as the healthy worker effect cannot be excluded. In addition, the effectiveness of the intervention to reduce allergen exposures was not evaluated. In a retrospectively assembled cohort of new employees working with laboratory animals, an education programme may have contributed to the decrease in annual incidence rate of laboratory animal allergy from 42% to 15% over 4 yrs [46, 47]. Comparison of the symptom prevalence in each entry year for each new cohort entering the workforce indicates a lower prevalence in cohorts that entered after the start of the intervention. However, trends over time cannot be interpreted because the occurrence of laboratory animal allergy was not explored by considering the proportion exposed and not expressed as a rate with person-time of follow-up in the denominator. Loss to follow-up was considerable, and the risk of developing laboratory animal allergy from year to year is likely to have been underestimated as a result. It is unclear if the apparent reduction in laboratory animal allergy occurrence was accompanied by a reduction in allergen levels since no allergen exposure data was obtained.

What is the effectiveness of reducing skin exposures to prevent occupational asthma?

To our knowledge there are no studies that address whether reducing skin exposure to occupational allergens can prevent occupational asthma. Elimination of the exposure, the preferred approach to preventing occupational asthma, reduces all routes of exposure, including skin exposure.

Concern that skin exposure to chemical allergens and even possibly to HMW protein allergens may increase asthma risk has arisen based on several lines of “evidence”, including clinical experience and case reports, animal studies, and limited epidemiological findings. Animal studies have clearly demonstrated that skin exposure to chemical allergens, such as isocyanates, can induce type 2 helper T-cell-like sensitisation and subsequent airway inflammation following inhalation challenge [51]. Of note, skin exposure can be more effective than inhalation exposure at inducing sensitisation, and lower skin sensitising doses more effective than higher doses in producing asthmatic responses [5254].

Assessment of skin exposure

To assess whether human skin exposure to allergens increases asthma risk requires methods to sample and quantify skin exposure. Such methods are not as well developed and not as widely available as airborne exposure methods. Skin exposure assessment is further complicated by factors such as the frequently sporadic nature of skin exposure, uncertainty about skin uptake, unknown effectiveness of protective clothing, mixed exposures, and the challenge of separating the risks of skin versus inhalational exposures. Despite these challenges, investigators have recently quantified isocyanate skin exposures in exposed workers using novel sampling and analytical approaches, including skin surface wipe sampling, skin tape stripping, and sampling of inner gloves and pads under PPE (table 4) [56, 58, 6063]. Analysis of consecutive skin tape strips has documented dermal penetration of isocyanate, and correlations between isocyanate skin exposure and urinary metabolites support skin uptake [6062]. These studies have also demonstrated frequent isocyanate skin exposure among workers in several work settings despite the use of standard PPE, such as gloves [56, 60, 63]. They have also demonstrated that while in some work settings skin and respiratory exposures are highly correlated, in others settings they are not, potentially enabling the differentiation of skin and respiratory health effects. Incorporation of skin exposure metrics into epidemiological studies of exposed workers should enable investigators to better define the risks of skin exposure and also the effectiveness of industrial hygiene controls, including protective clothing, to reduce such exposures.

Table 4. Selected literature on occupational skin exposure to isocyanates.
First author [ref.] Main conclusion Origin Study type Exposure/occupation Subjects
Pronk [19] Inhalation HDI exposure associated with tasks involving aerosolisation
Skin exposure assessed by extraction of HDI from nitrile gloves; associated with paint-handling tasks and glove use
HDA detected in 36% of repair shop workers, 10% of industrial workers
HDI oligomers main exposure
Literature search Cross-sectional study
Before and after shift sampling
HDI oligomers, auto-body repair workers 68 paired inhalation and skin samples from auto repair shops; 239 urine samples from 45 workers
27 paired inhalation and skin samples from five industrial companies; 52 urine samples from 10 painters
Robert [55] MDA detectable in 73% of post-shift urine samples; significantly higher than pre-shift levels
Highest MDA levels associated with spraying or hot processes
Skin exposure associated with significant MDA levels in urine
Literature search Cross-sectional study MDI polyurethane workers 169 workers from 19 French factories and 120 controls
Bello [56] Quantitative skin wipe sampling method developed
92% of samples under PPE had detectable isocyanate levels, mostly pHDI
Highest total isocyanate concentrations associated with spraying and mixing
Literature search Cross-sectional study HDI auto-body repair workers 185 samples from 81 auto-body shop painters and technicians during different tasks
43 samples under PPE
Todd [57] 8–21% of workers exposed to mixtures of chemicals more than OELs; 39–69% of surface samples positive for isocyanates using qualitative CLI Swypes™#
PPE and IH controls not adequate
Literature search Cross-sectional study Workers at footwear and equipment factories 286 personal air samples, 64 surface, tool or hand samples from four factories in Thailand
Fent [58] Log-transformed concentrations of HDI in skin of workers correlated with log-transformed product of air concentration and painting time (r=0.79, p<0.001) Literature search Cross-sectional study HDI auto-body spray painters 13 auto-body spray painters: air and skin samples
Liu [59] Skin exposure algorithm using diaries, task-based skin sampling and PPE
Median daily skin exposure index estimated for each worker
Associated with job category
Weakly correlated with daily airborne exposure
Literature search Cross-sectional study Workers in auto-body shops 232 workers in 33 shops:
893 exposure person-days skin exposure, work diary
Fent [60] Isocyanurate predominant isocyanate
Dermal HDI concentrations higher in those not wearing gloves/overalls
Isocyante detected on skin during 23% of paint tasks
Linear mixed modelling identified breathing-zone concentration and paint time significant predictors skin concentration
Literature search Cross-sectional study HDI auto-body spray painters 47 spray painters dermal and inhalational exposure assessment
15 painters no gloves
Flack [61] HDA detected in 76% plasma samples
Correlation between plasma HDA and same day dermal exposures, low but significant, correlation between HDA and 20–60 day dermal exposure higher (r=0.36)
Literature search Cohort study HDI auto-body shop painters 46 spray painters: blood, inhalation and dermal exposures measured
288 tasks
Liljelind [62] Average personal air concentrations below Swedish exposure limit
Tape stripping used to measure MDI skin exposure
Decreasing levels of MDI in consecutive tape strips per site indicate dermal penetration
Literature search Cross-sectional study MDI iron-foundry workers 19 workers in different areas of foundry; tape strip dermal sampling repeated on five exposed skin areas and air sampling

HDI: hexamethylene diisocyanate; HDA: hexamethylene diamine; MDA: methylenedianiline diisocyanate; MDI: methylene diphenyl diisocyante; PPE: personal protective equipment; pHDI: polymeric HDI isocyanate; OEL: occupational exposure limit; IH: industrial hygiene. #: skin wipes that provide a visible indication of skin exposure (Colorimetric Laboratories, Inc., Plaines, IL, USA).

Isocyanate skin exposure and asthma

To date, the evidence that human skin exposure to allergens can increase the risk of asthma comes primarily from case reports of isocyanate asthma or sensitisation in settings where isocyanate skin contact has been reported or suspected, and where airborne isocyanate levels are very low (table 5). Most of these cases have involved workplace exposure to methylene diphenyl diisocyanate (MDI), which is much less volatile than the other commonly used isocyanates, and is frequently handled as a liquid, creating greater opportunity for exposure through skin contamination than through inhalation. To date, the primary epidemiological study that addressed the risk of asthma related to occupational skin exposure was a cross-sectional and 1-yr follow-up study of 214 newly employed workers in a wood manufacturing plant that used MDI resins [64]. Skin exposure was assessed by a questionnaire regarding skin staining, MDI on clothes and type of work. 27% of workers in areas with high potential for liquid MDI exposure reported new-onset asthma-like symptoms versus 0% in low-potential areas. Skin staining and MDI on clothes, and working around and cleaning up MDI was associated with new asthma-like symptoms. Air monitoring data (six personal breathing zone samples) showed no detectable MDI and a single glove wipe sample that was taken had 0.078 mg of MDI. The authors concluded that skin might be a site for potential immunological sensitisation and subsequent risk for development of respiratory symptoms. In other studies, an investigation of approximately 500 coal miners who injected MDI for rock consolidation identified about 15 workers with a diagnosis of occupational asthma or sensitisation (positive MDI-immunoglobulin (Ig)E) [65]. Air sampling for MDI was reported to show very low levels (<1 ppb) and MDI skin exposure was reported to occur commonly among these workers. The authors concluded that isocyanate skin exposure probably contributed to MDI sensitisation and asthma [65]. Surveillance of 243 workers exposed to MDI in a polyurethane mould plant with MDI air levels consistently <0.005 ppm identified three cases of MDI asthma and one case of MDI-induced cutaneous anaphylaxis [66]. In one case the onset of asthma symptoms occurred after an MDI spill. All four workers were reported to work in areas with potential for skin contact with uncured MDI.

Table 5. Literature addressing the association between skin exposure and asthma.
First author [ref.] Main conclusion Origin SIGN grade Study type Exposure/occupation Subjects
Petsonk [64] 27% of workers in areas with high potential for liquid MDI exposure reported new-onset asthma-like symptoms versus 0% in low-potential areas
Skin staining and MDI on clothes, cleaning up MDI was associated with these symptoms
Asthma symptoms were associated with variable airflow limitation and MDI-specific IgE
Air monitoring data (six personal breathing zone samples) showed no detectable MDI
A single glove wipe sample was taken and had 0.078 mg MDI
The skin may be a site for sensitisation and subsequent risk for development of respiratory symptoms
Literature search 2+ Cohort (1-yr follow-up) MDI: wood manufacturing plant 214 plant employees, 83% participated in follow-up survey
Questionnaires prior to use of MDI and every 6 months thereafter
Serial peak flows, spirometry, methacholine challenge, MDI-IgE, skin prick testing performed at certain times in selected workers
Lenaerts-Langanke [65] Population: 50% reported skin exposure
6.5% of the pressure grouters had MDI-related respiratory symptoms
Two had positive MDI-specific inhalation challenge
Air exposures were very low (<1 ppb)
6 out of 8 pressure grouters with heavy skin exposure MDI metabolites in urine
Reported skin irritation from MDI uncommon
MDI skin exposure common
MDI sensitisation through skin contact possible
Important to prevent skin exposure
Literature search 3 Cross-sectional study MDI: coal miners Three populations:
216 pressure grouters who inject MDI polyurethane foam (55 control miners)
245 exposed miners
Eight pressure grouters with heavy polyurethane skin exposure
Shahzad [67] Asthma prevalence 10.8% (69/641)
Multivariate analysis: asthma associated with educational status, ethnicity, smoking, glove use (never use OR 3.28, 95% CI 1.72–6.26), perceived allergy, duration of work
Protective effect of glove use may be due to protection of skin from sensitising chemicals
Literature search 2- Cross-sectional study Leather tannery workers in Pakistan 641 workers in 95 tanneries, all workers enrolled working with tanning process
Questionnaire
No exposure information
Bernstein [66] Based on questionnaire-derived diagnoses of 243 workers: 4% workers with occupational asthma, 36% occupational rhinitis, and 11% irritant lower respiratory symptoms
Two workers (0.4%) had MDI-specific IgG, both worked in finishing area where they had direct MDI skin contact
Plant designed to minimise MDI exposures 24-h·day−1 air monitoring area samples
All air levels <0.005 ppm
Selected workers further medical evaluation: three cases occupational asthma from MDI (1.2%) and one case MDI-induced cutaneous anaphylaxis (positive MDI skin test and MDI-IgE)
These four workers worked in areas with potential MDI skin contact
Conclusions: low prevalence of sensitisation and occupational asthma
Authors recommend avoid MDI skin contact
Literature search 3 Cross-sectional study/case series isocyanate asthma MDI: polyurethane mould plant 243 workers exposed to MDI: questionnaire and serum antibody tests
147 workers on polyurethane mould lines
3 cases of isocyanate asthma
Donnelly [68] Nurse with MDI asthma
Case confirmed by specific inhalation challenge with MDI cast material (39% decreased FEV1)
Literature search 3 Case study MDI: hospital synthetic plaster casts One nurse working with MDI-containing plaster casts for 4 yrs
Nemery [69] Surface worker who handled half-empty MDI drums at the mine without safety precautions developed probable isocyanate asthma
Risk of isocyanate exposure with polyurethane rock consolidation
Literature search 3 Case study MDI: coal miners Surface worker from coal mine
Dernehl [70] Mentions personal experience: isocyanate skin exposure increases risk asthma Cited in article 3 Personal experience MDI Workers with respirator protection and repeated skin contact

SIGN: Scottish Intercollegiate Guidelines Network; MDI: methylene diphenyl diisocyanate; Ig: immunoglobulin; FEV1: forced expiratory volume in 1 s.

Studies among other groups of workers are also very limited. A cross-sectional study of 641 tannery workers found an asthma prevalence of 10.8% [67]. Multiple regression analysis showed the strongest risk factor for asthma was not using gloves (OR 3.28, 95% CI 1.72–6.26), with educational status, ethnicity, smoking, perceived allergy and duration of work also being significant risk factors (table 5]).

Several studies have provided data on the effectiveness of currently recommended PPE in preventing skin exposure to isocyanates. Although typically lower amounts are noted than on unprotected skin, isocyanate has been detected underneath latex and nitrile gloves, cartridge respirators and protective clothing [56, 60, 63].

In summary, skin exposure to certain occupational asthma-inducing agents probably increases the risk of occupational asthma, despite limited epidemiological studies to date. The contribution of skin exposure to asthma risk probably varies greatly with different allergenic exposures, work processes and settings, as well as other factors than can alter skin barrier function. Dose–response relationships with allergens frequently are nonlinear, and there are insufficient data to identify safe skin exposure levels for sensitisers. There are data indicating that currently recommended PPE may not be effective in limiting skin exposure to isocyanate chemicals in some settings. Improved skin exposure methodologies should facilitate the incorporation of skin exposure assessment into epidemiology studies to better define exposure risk factors and also help evaluate the effectiveness of preventive interventions. In the meantime, it would be prudent to increase awareness of the potential risks of allergen skin exposure and to limit such exposures.

What is the effectiveness of PPE to prevent occupational sensitisation and asthma?

PPE and the hierarchy of controls

In the hierarchy of controls for occupational health hazards, eliminating or minimising exposures at the source or in the environment is considered more effective than the worker using PPE [71]. The success of respiratory personal protection requires an ongoing commitment by employers and employees to a programme that includes selection, cleaning, maintenance and storage of equipment, as well as training, fit testing and medical monitoring of users. Respirators are best used as an interim measure while efforts to control exposures at the source or in the environment are being implemented, or when controls at these other levels are not possible. Perhaps, since respirators are not considered an optimal way to control exposures, they have often been used in conjunction with other control activities at the source and/or environmental level. Such comprehensive programmes that include the use of respirators have been implemented for workers exposed to laboratory animals [47, 7274], dusts and fumes in aluminium production [75], diisocyanates [76] and disinfectants [76, 77]. While many of these programmes have reported success at prevention, it is not possible to determine the contribution made by respirators alone.

Previous statements from professional organisations

Two recent statements from professional organisations address use of respirators for primary prevention of work-related asthma. An expert panel convened by the American College of Chest Physicians (ACCP) produced a publication on the diagnosis and management of work-related asthma [78]. This document advises primary prevention by controlling exposures to known workplace sensitisers and irritants, briefly citing a variety of methods, including respirators. The examples of using respirators to control exposures involved exposure to hexahydrophthalic anhydride (HHPA) [79] and isocyanates [80]. The British Occupational Health Research Foundation (BOHRF) also developed guidelines for occupational asthma [81]. Similar to the ACCP document, the BOHRF guidelines emphasise reducing airborne exposures to occupational asthma agents. The advice specific to respiratory protective equipment (RPE) was: “The use of RPE reduces the incidence of, but does not completely prevent, occupational asthma” [81]. The evidence cited included the same article used in the ACCP document for HHPA [79] and two references for control of exposure to isocyanates [64, 82] not cited by the ACCP.

Indirect evidence for effectiveness of PPE in preventing occupational asthma

An updated review of the medical literature revealed indirect evidence that use of respiratory protective devices might prevent asthma onset, by demonstrating that respirators can reduce exposures to agents that can cause occupational asthma. These studies investigated: air purifying respirators [83] and half-face respirators with particulate/organic vapour/formaldehyde filters [84] used by firefighters; air purifying respirators [85], half-mask respirators with frequent cartridge changes [86], and half-face air purifying or full-face air-supplied respirators [87] for workers exposed to styrene; hood style supplied air respirators used to reduce exposure to chromium and other materials during sanding in aircraft manufacturing [88]; P2 facemasks and fresh-air helmets to reduce levels of rodent allergens among laboratory animal handlers [89]; and certified two-tie protective masks that reduced total particle concentrations by 97% in swine confinement buildings [90].

This indirect evidence takes on somewhat more significance for agents that have a positive dose–response relationship with occupational asthma, since a reduction in exposure should decrease the number of cases. Such a relationship has been reported for wheat allergen [91], and investigators compared exposure levels measured inside a P2 particle filter facemask to measurements taken outside the facemask [92]. Exposure levels were reduced by 93–96% using the facemasks, and the investigators concluded that these respirators might help to prevent baker's asthma.

Several studies have examined the effectiveness of respiratory protective devices intended to limit isocyanate exposure in paint operations. A study of 22 spray painters working in automobile body shops measured isocyanates both inside and outside negative pressure, air-purifying half-face piece respirators with organic vapour cartridges and paint pre-filters [80]. The authors concluded that these respirators provided reasonably effective protection if the workers were trained and fit tested. In a study conducted in a test chamber, air purifying respirators with organic vapour cartridges were, on average, 99.4% efficient based on comparisons of isocyanate exposures inside and outside the respirators [93]. In another study of spray painters, researchers concluded that air-fed visors provided good protection if they were well maintained and the airflow was sufficiently high [94].

Direct evidence for effectiveness of PPE in preventing occupational asthma

Despite the encouraging findings that respirators can substantially reduce exposures to asthma agents, these studies did not directly test whether respirator use is associated with a decline in the onset of occupational asthma. The two studies for isocyanates and respirators in the BOHRF guidelines at least suggest such a benefit. In one study, automobile body shop employees who applied paints containing isocyanates were approximately one-third as likely to have occupational asthma symptoms if they used a positive pressure respirator [82]. However, a relatively small number of participants used this respirator and the finding was not statistically significant [82]. A second study provided evidence that inconsistent use of respiratory protection might have negative consequences. Specifically, isocyanate-exposed workers at a wood products plant were at greater risk for new-onset asthma-like symptoms if they removed their respirators even briefly (p<0.05) [64].

A more direct investigation of the value of respiratory protection for primary prevention was conducted among workers who were manufacturing an epoxy resin that required HHPA (table 6) [79]. This is the same study cited in both the ACCP and BOHRF documents. Study participants were offered a choice of three different respirators: a disposable dust and mist respirator, a half-face organic vapour respirator, or a full-face organic vapour respirator. The highest annual incidence for asthma over the 7 yrs of follow-up was 2%, compared to approximately 10% that was observed in employees before the introduction of respirators. There was no statistically significant difference between respirators, but none of the workers who wore the full-face respirators developed occupational asthma, even those who worked in high-exposure jobs.

Table 6. Evidence for effectiveness of respirators to prevent onset of occupational asthma.
Main conclusion Origin SIGN grade Study type Exposure/ occupation Subjects
Grammer [79] Before introduction of respirators, annual incidence for asthma was 10%
7 yrs after respirators were introduced, highest annual incidence was 2%
Authors concluded respirators can reduce incidence of occupational immunological respiratory disease, including occupational asthma, in workers exposed to HHPA
Literature search 2+ Prospective cohort study following intervention (introduce respirators) Acid anhydride 66 new workers who made HHPA

SIGN: Scottish Intercollegiate Guidelines Network; HHPA: hexahydrophthalic anhydride.

Conclusion

There is little direct evidence in the literature that respirators are effective for primary prevention of occupational asthma. Additional studies are needed, especially for settings in which other controls are not possible.

DISCUSSION

Based on the review of the literature as already summarised, we arrived at the following statements, recommendations and comments on future research.

Statements

The strength of the evidence for each statement was graded according to the three-star system of the Royal College of General Practitioners (RCGP), which includes the quality and the quantity of the evidence (*: limited; **: moderate; ***: strong), as previously described [95].

Complete elimination of the exposure is the most straightforward approach to reducing the burden of disease associated with occupational allergy and asthma. (**).

It is extremely likely that exposure reduction will lead to a reduction of the disease burden for occupational asthma, as indicated by exposure–response relationships. However, there is limited evidence provided by a few ecological and surveillance studies. (*).

Substitution of NRL greatly reduces NRL sensitisation and the occurrence of NRL-related asthma. (***).

Skin exposure to allergens occurs in the workplace, but there is limited evidence that skin exposure contributes to the onset of occupational sensitisation and asthma. RCGP: limited evidence mainly provided by case reports and cross-sectional studies. (*).

Use of respiratory protective equipment can contribute to primary prevention of occupational asthma. (*).

Recommendations

The recommendations are detailed in table 7.

Table 7. Recommendations according to the Grading of Recommendations Assessment, Development and Evaluation (GRADE) working group.

GRADE recommendations Strength of recommendation Level of evidence
Exposure elimination is the strongest preventive approach to reduce the disease burden of occupational asthma and is the preferred primary prevention approach Strong High
If elimination is not possible, reduction is the second-best option for primary prevention for occupational asthma based on exposure–response relationships Strong Moderate
The evidence for the effectiveness of respirators in preventing occupational asthma is limited and other options higher in the hierarchy of controls for occupational exposures, notably eliminating or minimising exposures at the source or in the environment, should be used preferentially Strong Moderate
Do not use powdered allergen-rich natural rubber latex gloves Strong High
Minimise skin exposure to asthma-inducing agents Strong Low

The strength and clinical relevance of the recommendation was classified according to the system of the Grading of Recommendations Assessment, Development and Evaluation (GRADE) working group [96].

Future aspects

In general, studies that make use of strong analytical designs, such as randomised controlled trials and controlled intervention studies, are potentially possible for allergen exposure. Observational studies that focus on disease occurrence in relation to exposure have limitations. Exposure studies focusing on the evaluation of allergen exposures and exposure interventions are strongly encouraged. More evidence is needed for all types of preventive actions, including improved ventilation, education of workers, changes in work organisation, and use of different types of PPE.

There is a need to further explore the role of skin exposure in relation to development of sensitisation and disease occurrence. Additional research is needed to demonstrate the effectiveness of primary preventive measures on allergen exposure and occurrence of allergy and asthma.

Acknowledgments

The members of the Task Force are as follows. X. Baur (Chair: Institute for Occupational and Maritime Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany); T. Sigsgaard (Co-Chair: Århus University, Institute of Environmental and Occupational Medicine, School of Public Health, Århus C, Denmark); T.B. Aasen (Haukeland University Hospital, Bergen, Norway); P.S. Burge (Heart of England NHS Foundation Trust, Dept Respiratory Medicine, Birmingham, UK); H. Dressel (Städt. Klinikum München GmbH Klinikum Neuperlach Zentrum für Akutgeriatrie und Frührehabilitation, Munich, Germany); D. Heederik (Environmental Epidemiology Division, Institute for Risk Assessment Sciences (IRAS), University of Utrecht, Utrecht, the Netherlands); P.K. Henneberger (National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Morgantown, WV, USA); P. Maestrelli (Dept of Environmental Medicine and Public Health, University of Padova, Padova, Italy); C.A. Redlich (Yale University, Occupational and Environmental Medicine Program, New Haven, CT, USA); J. Rooyackers (Netherlands Expertise Center for Occupational Respiratory Disorders – NECORD IRAS NKAL, Utrecht, the Netherlands); V. Schlünssen (Århus Universitet, Århus C, Denmark); O. Vandenplas (Dept of Chest Medicine, Mont-Godinne Hospital, Université Catholique de Louvain, Yvoir, Belgium); D. Wilken (Institute for Occupational and Maritime Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany).

Footnotes

Support Statement

The work of the Task Force on theManagement ofWork-related Asthma was funded by the European Respiratory Society. The findings and conclusions in this report are those of the author and do not necessarily represent the views of the National Institute for Occupational Safety and Health.

Statement of Interest

None declared.

Provenance

Submitted article, peer reviewed.

REFERENCES

  • 1.Rijnkels JM, Smid T, Van den Aker EC, et al. Prevention of work-related airway allergies; summary of the advice from the Health Council of the Netherlands. Allergy 2008; 63: 1593–1596. [DOI] [PubMed] [Google Scholar]
  • 2.Fransman W, Schinkel J, Meijster T, et al. Development and evaluation of an exposure control efficacy library (ECEL). Ann Occup Hyg 2008; 52: 567–575. [DOI] [PubMed] [Google Scholar]
  • 3.Lazovich D, Parker DL, Brosseau LM, et al. Effectiveness of a worksite intervention to reduce an occupational exposure: the Minnesota wood dust study. Am J Public Health 2002; 92: 1498–1505. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Brosseau LM, Parker DL, Lazovich D, et al. Designing intervention effectiveness studies for occupational health and safety: the Minnesota Wood Dust Study. Am J Ind Med 2002; 41: 54–61. [DOI] [PubMed] [Google Scholar]
  • 5.Meijster T, Warren N, Heederik D, et al. What is the best strategy to reduce the burden of occupational asthma and allergy in bakers? Occup Environ Med 2011; 68: 176–182. [DOI] [PubMed] [Google Scholar]
  • 6.Baur X, Sigsgaard T, Aasen TBet al. Guidelines for the management of work-related asthma. Eur Respir J 2012; 39: 529–545. [DOI] [PubMed] [Google Scholar]
  • 7.Arts JH, Mommers C, de Heer C. Dose–response relationships and threshold levels in skin and respiratory allergy. Crit Rev Toxicol 2006; 36: 219–251. [DOI] [PubMed] [Google Scholar]
  • 8.Brooks SM, Edwards JJ, Apol A, et al. An epidemiologic study of workers exposed to western red cedar and other wood dusts. Chest 1981; 80: Suppl. 1, 30–32. [DOI] [PubMed] [Google Scholar]
  • 9.Cullinan P, Cook A, Gordon S, et al. Allergen exposure, atopy and smoking as determinants of allergy to rats in a cohort of laboratory employees. Eur Respir J 1999; 13: 1139–1143. [DOI] [PubMed] [Google Scholar]
  • 10.Heederik D, Venables KM, Malmberg P, et al. Exposure–response relationships for work-related sensitization in workers exposed to rat urinary allergens: results from a pooled study. J Allergy Clin Immunol 1999; 103: 678–684. [DOI] [PubMed] [Google Scholar]
  • 11.Houba R, Heederik D, Doekes G. Wheat sensitization and work-related symptoms in the baking industry are preventable. An epidemiologic study. Am J Respir Crit Care Med 1998; 158: 1499–1503. [DOI] [PubMed] [Google Scholar]
  • 12.Houba R, Heederik DJ, Doekes G, et al. Exposure-sensitization relationship for alpha-amylase allergens in the baking industry. Am J Respir Crit Care Med 1996; 154: 130–136. [DOI] [PubMed] [Google Scholar]
  • 13.Kruize H, Post W, Heederik D, et al. Respiratory allergy in laboratory animal workers: a retrospective cohort study using pre-employment screening data. Occup Environ Med 1997; 54: 830–835. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Meredith SK, Bugler J, Clark RL. Isocyanate exposure and occupational asthma: a case-referent study. Occup Environ Med 2000; 57: 830–836. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Nieuwenhuijsen MJ, Heederik D, Doekes G, et al. Exposure-response relations of alpha-amylase sensitisation in British bakeries and flour mills. Occup Environ Med 1999; 56: 197–201. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Nieuwenhuijsen MJ, Putcha V, Gordon S, et al. Exposure-response relations among laboratory animal workers exposed to rats. Occup Environ Med 2003; 60: 104–108. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Ott MG. Occupational asthma, lung function decrement, and toluene diisocyanate (TDI) exposure: a critical review of exposure-response relationships. Appl Occup Environ Hyg 2002; 17: 891–901. [DOI] [PubMed] [Google Scholar]
  • 18.Peretz C, de Pater N, de Monchy J, et al. Assessment of exposure to wheat flour and the shape of its relationship with specific sensitization. Scand J Work Environ Health 2005; 31: 65–74. [DOI] [PubMed] [Google Scholar]
  • 19.Pronk A, Preller L, Raulf-Heimsoth M, et al. Respiratory symptoms, sensitization, and exposure response relationships in spray painters exposed to isocyanates. Am J Respir Crit Care Med 2007; 176: 1090–1097. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Schlunssen V, Schaumburg I, Heederik D, et al. Indices of asthma among atopic and non-atopic woodworkers. Occup Environ Med 2004; 61: 504–511. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Bulat P, Myny K, Braeckman L, et al. Exposure to inhalable dust, wheat flour and alpha-amylase allergens in industrial and traditional bakeries. Ann Occup Hyg 2004; 48: 57–63. [DOI] [PubMed] [Google Scholar]
  • 22.Burdorf A, Lillienberg L, Brisman J. Characterization of exposure to inhalable flour dust in Swedish bakeries. Ann Occup Hyg 1994; 38: 67–78. [DOI] [PubMed] [Google Scholar]
  • 23.Meijster T, Tielemans E, de Pater N, et al. Modelling exposure in flour processing sectors in the Netherlands: a baseline measurement in the context of an intervention program. Ann Occup Hyg 2007; 51: 293–304. [DOI] [PubMed] [Google Scholar]
  • 24.Alwis U, Mandryk J, Hocking AD, et al. Dust exposures in the wood processing industry. Am Ind Hyg Assoc J 1999; 60: 641–646. [DOI] [PubMed] [Google Scholar]
  • 25.Friesen MC, Davies HW, Teschke K, et al. Predicting historical dust and wood dust exposure in sawmills: model development and validation. J Occup Environ Hyg 2005; 2: 650–658. [DOI] [PubMed] [Google Scholar]
  • 26.Scheeper B, Kromhout H, Boleij JS. Wood-dust exposure during wood-working processes. Ann Occup Hyg 1995; 39: 141–154. [PubMed] [Google Scholar]
  • 27.Schlunssen V, Jacobsen G, Erlandsen M, et al. Determinants of wood dust exposure in the Danish furniture industry – results from two cross-sectional studies 6 years apart. Ann Occup Hyg 2008; 52: 227–238. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Hollund BE, Moen BE. Chemical exposure in hairdresser salons: effect of local exhaust ventilation. Ann Occup Hyg 1998; 42: 277–282. [PubMed] [Google Scholar]
  • 29.LaMontagne AD, Radi S, Elder DS, et al. Primary prevention of latex related sensitisation and occupational asthma: a systematic review. Occup Environ Med 2006; 63: 359–364. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Allmers H, Schmengler J, Skudlik C. Primary prevention of natural rubber latex allergy in the German health care system through education and intervention. J Allergy Clin Immunol 2002; 110: 318–323. [DOI] [PubMed] [Google Scholar]
  • 31.Heilman DK, Jones RT, Swanson MC, et al. A prospective, controlled study showing that rubber gloves are the major contributor to latex aeroallergen levels in the operating room. J Allergy Clin Immunol 1996; 98: 325–330. [DOI] [PubMed] [Google Scholar]
  • 32.Jones KP, Rolf S, Stingl C, et al. Longitudinal study of sensitization to natural rubber latex among dental school students using powder-free gloves. Ann Occup Hyg 2004; 48: 455–457. [DOI] [PubMed] [Google Scholar]
  • 33.Lee A, Nixon R, Frowen K. Reduction of use of latex gloves in food handlers: an intervention study. Contact Dermatitis 2001; 44: 75–79. [DOI] [PubMed] [Google Scholar]
  • 34.Levy D, Allouache S, Chabane MH, et al. Powder-free protein-poor natural rubber latex gloves and latex sensitization. JAMA 1999; 281: 988. [DOI] [PubMed] [Google Scholar]
  • 35.Liss GM, Tarlo SM. Natural rubber latex-related occupational asthma: association with interventions and glove changes over time. Am J Ind Med 2001; 40: 347–353. [DOI] [PubMed] [Google Scholar]
  • 36.Saary MJ, Kanani A, Alghadeer H, et al. Changes in rates of natural rubber latex sensitivity among dental school students and staff members after changes in latex gloves. J Allergy Clin Immunol 2002; 109: 131–135. [DOI] [PubMed] [Google Scholar]
  • 37.Tarlo SM, Sussman GL, Holness DL. Latex sensitivity in dental students and staff: a cross-sectional study. J Allergy Clin Immunol 1997; 99: 396–401. [DOI] [PubMed] [Google Scholar]
  • 38.Tarlo SM, Easty A, Eubanks K, et al. Outcomes of a natural rubber latex control program in an Ontario teaching hospital. J Allergy Clin Immunol 2001; 108: 628–633. [DOI] [PubMed] [Google Scholar]
  • 39.Cadot P, Tits G, Bussels L, et al. Asthma and hand dermatitis to leek. Allergy 2001; 56: 192–193. [DOI] [PubMed] [Google Scholar]
  • 40.Meijster T, Tielemans E, Heederik D. Effect of an intervention aimed at reducing the risk of allergic respiratory disease in bakers: change in flour dust and fungal alpha-amylase levels. Occup Environ Med 2009; 66: 543–549. [DOI] [PubMed] [Google Scholar]
  • 41.Smith TA. Preventing baker's asthma: an alternative strategy. Occup Med (Lond) 2004; 54: 21–27. [DOI] [PubMed] [Google Scholar]
  • 42.Grammer LC, Ditto AM, Tripathi A, et al. Prevalence and onset of rhinitis and conjunctivitis in subjects with occupational asthma caused by trimellitic anhydride (TMA). J Occup Environ Med 2002; 44: 1179–1181. [DOI] [PubMed] [Google Scholar]
  • 43.Tarlo SM, Liss GM, Yeung KS. Changes in rates and severity of compensation claims for asthma due to diisocyanates: a possible effect of medical surveillance measures. Occup Environ Med 2002; 59: 58–62. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Cathcart M, Nicholson P, Roberts D, et al. Enzyme exposure, smoking and lung function in employees in the detergent industry over 20 years. Medical Subcommittee of the UK Soap and Detergent Industry Association. Occup Med (Lond) 1997; 47: 473–478. [DOI] [PubMed] [Google Scholar]
  • 45.Schweigert MK, Mackenzie DP, Sarlo K. Occupational asthma and allergy associated with the use of enzymes in the detergent industry – a review of the epidemiology, toxicology and methods of prevention. Clin Exp Allergy 2000; 30: 1511–1518. [DOI] [PubMed] [Google Scholar]
  • 46.Botham PA, Davies GE, Teasdale EL. Allergy to laboratory animals: a prospective study of its incidence and of the influence of atopy on its development. Br J Ind Med 1987; 44: 627–632. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Fisher R, Saunders WB, Murray SJ, et al. Prevention of laboratory animal allergy. J Occup Environ Med 1998; 40: 609–613. [DOI] [PubMed] [Google Scholar]
  • 48.Juniper CP, Roberts DM. Enzyme asthma: fourteen years' clinical experience of a recently prescribed disease. J Soc Occup Med 1984; 34: 127–132. [DOI] [PubMed] [Google Scholar]
  • 49.Cullinan P, Harris JM, Newman Taylor AJ, et al. An outbreak of asthma in a modern detergent factory. Lancet 2000; 356: 1899–1900. [DOI] [PubMed] [Google Scholar]
  • 50.van Rooy FG, Houba R, Palmen N, et al. A cross-sectional study among detergent workers exposed to liquid detergent enzymes. Occup Environ Med 2009; 66: 759–765. [DOI] [PubMed] [Google Scholar]
  • 51.Redlich CA. Skin exposure and asthma: is there a connection? Proc Am Thorac Soc 2010; 7: 134–137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Ban M, Morel G, Langonne I, et al. TDI can induce respiratory allergy with Th2-dominated response in mice. Toxicology 2006; 218: 39–47. [DOI] [PubMed] [Google Scholar]
  • 53.Herrick CA, Xu L, Wisnewski AV, et al. A novel mouse model of diisocyanate-induced asthma showing allergic-type inflammation in the lung after inhaled antigen challenge. J Allergy Clin Immunol 2002; 109: 873–878. [DOI] [PubMed] [Google Scholar]
  • 54.Pauluhn J. Brown Norway rat asthma model of diphenylmethane-4,4'-diisocyanate (MDI): analysis of the elicitation dose-response relationship. Toxicol Sci 2008; 104: 320–331. [DOI] [PubMed] [Google Scholar]
  • 55.Robert A, Ducos P, Francin JM, et al. Biological monitoring of workers exposed to 4,4'-methylenediphenyl diisocyanate (MDI) in 19 French polyurethane industries. Int Arch Occup Environ Health 2007; 80: 412–422. [DOI] [PubMed] [Google Scholar]
  • 56.Bello D, Redlich CA, Stowe MH, et al. Skin exposure to aliphatic polyisocyanates in the auto body repair and refinishing industry: II. A quantitative assessment. Ann Occup Hyg 2008; 52: 117–124. [DOI] [PubMed] [Google Scholar]
  • 57.Todd LA, Mottus K, Mihlan GJ. A survey of airborne and skin exposures to chemicals in footwear and equipment factories in Thailand. J Occup Environ Hyg 2008; 5: 169–181. [DOI] [PubMed] [Google Scholar]
  • 58.Fent KW, Jayaraj K, Ball LM, et al. Quantitative monitoring of dermal and inhalation exposure to 1,6-hexamethylene diisocyanate monomer and oligomers. J Environ Monit 2008; 10: 500–507. [DOI] [PubMed] [Google Scholar]
  • 59.Liu Y, Stowe MH, Bello D, et al. Skin exposure to aliphatic polyisocyanates in the auto body repair and refinishing industry: III. A personal exposure algorithm. Ann Occup Hyg 2009; 53: 33–40. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Fent KW, Trelles Gaines LG, Thomasen JM, et al. Quantification and statistical modeling–part II: dermal concentrations of monomeric and polymeric 1,6-hexamethylene diisocyanate. Ann Occup Hyg 2009; 53: 691–702. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Flack SL, Fent KW, Trelles Gaines LG, et al. Quantitative plasma biomarker analysis in HDI exposure assessment. Ann Occup Hyg 2010; 54: 41–54. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Liljelind I, Norberg C, Egelrud L, et al. Dermal and inhalation exposure to methylene bisphenyl isocyanate (MDI) in iron foundry workers. Ann Occup Hyg 2010; 54: 31–40. [DOI] [PubMed] [Google Scholar]
  • 63.Pronk A, Yu F, Vlaanderen J, et al. Dermal, inhalation, and internal exposure to 1,6-HDI and its oligomers in car body repair shop workers and industrial spray painters. Occup Environ Med 2006; 63: 624–631. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Petsonk EL, Wang ML, Lewis DM, et al. Asthma-like symptoms in wood product plant workers exposed to methylene diphenyl diisocyanate. Chest 2000; 118: 1183–1193. [DOI] [PubMed] [Google Scholar]
  • 65.Lenaerts-Langanke H. Isocyanat-bedingte Atemwegserkrankungen bei Bergleuten [Isocyanate-induced respiratory disease in coal miners]. Zbl Arbeitsmedizin 1992; 42: 2–25. [Google Scholar]
  • 66.Bernstein DI, Korbee L, Stauder T, et al. The low prevalence of occupational asthma and antibody-dependent sensitization to diphenylmethane diisocyanate in a plant engineered for minimal exposure to diisocyanates. J Allergy Clinical Immunol 1993; 92: 387–396. [DOI] [PubMed] [Google Scholar]
  • 67.Shahzad K, Akhtar S, Mahmud S. Prevalence and determinants of asthma in adult male leather tannery workers in Karachi, Pakistan: a cross sectional study. BMC Public Health 2006; 6: 292. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Donnelly R, Buick JB, Macmahon J. Occupational asthma after exposure to plaster casts containing methylene diphenyl diisocyanate. Occup Med (Lond) 2004; 54: 432–434. [DOI] [PubMed] [Google Scholar]
  • 69.Nemery B, Lenaerts L. Exposure to methylene diphenyl diisocyanate in coal mines. Lancet 1993; 341: 318. [DOI] [PubMed] [Google Scholar]
  • 70.Dernehl CU. Health hazards associated with polyurethane foams. J Occup Med 1966; 8: 59–62. [PubMed] [Google Scholar]
  • 71.Weeks JL, Levy BS, Wagner GR. Preventing occupational disease and injury. Washington, American Public Health Association, 1991. [Google Scholar]
  • 72.Goodno LE, Stave GM. Primary and secondary allergies to laboratory animals. J Occup Environ Med 2002; 44: 1143–1152. [DOI] [PubMed] [Google Scholar]
  • 73.Sjostedt L, Willers S, Orbaek P, et al. A seven-year follow-up study of lung function and methacholine responsiveness in sensitized and non-sensitized workers handling laboratory animals. J Occup Environ Med 1998; 40: 118–124. [DOI] [PubMed] [Google Scholar]
  • 74.Vanhanen M, Tuomi T, Tiikkainen U, et al. Risk of enzyme allergy in the detergent industry. Occup Environ Med 2000; 57: 121–125. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75.Sorgdrager B, de Looff AJ, de Monchy JG, et al. Occurrence of occupational asthma in aluminum potroom workers in relation to preventive measures. Int Arch Occup Environ Health 1998; 71: 53–59. [DOI] [PubMed] [Google Scholar]
  • 76.Pisati G, Baruffini A, Zedda S. Toluene diisocyanate induced asthma: outcome according to persistence or cessation of exposure. Br J Ind Med 1993; 50: 60–64. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 77.Fujita H, Sawada Y, Ogawa M, et al. [Health hazards from exposure to ortho-phthalaldehyde, a disinfectant for endoscopes, and preventive measures for health care workers]. Sangyo Eiseigaku Zasshi 2007; 49: 1–8. [DOI] [PubMed] [Google Scholar]
  • 78.Tarlo SM, Balmes J, Balkissoon R, et al. Diagnosis and management of work-related asthma: American College of Chest Physicians Consensus Statement. Chest 2008; 134: 1–41. [DOI] [PubMed] [Google Scholar]
  • 79.Grammer LC, Harris KE, Yarnold PR. Effect of respiratory protective devices on development of antibody and occupational asthma to an acid anhydride. Chest 2002; 121: 1317–1322. [DOI] [PubMed] [Google Scholar]
  • 80.Liu Y, Stowe MH, D B, et al. Respiratory protection from isocyanate exposure in the autobody repair and refinishing industry. J Occup Environ Hyg 2006; 3: 234–249. [DOI] [PubMed] [Google Scholar]
  • 81.Nicholson PJ, Cullinan P, Taylor AJ, et al. Evidence based guidelines for the prevention, identification, and management of occupational asthma. Occup Environ Med 2005; 62: 290–299. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 82.Cullen MR, Redlich CA, Beckett WS, et al. Feasibility study of respiratory questionnaire and peak flow recordings in autobody shop workers exposed to isocyanate-containing spray paint: observations and limitations. Occup Med (Lond) 1996; 46: 197–204. [DOI] [PubMed] [Google Scholar]
  • 83.Currie J, Caseman D, Anthony TR. The evaluation of CBRN canisters for use by firefighters during overhaul. Ann Occup Hyg 2009; 53: 523–538. [DOI] [PubMed] [Google Scholar]
  • 84.De Vos AJ, Cook A, Devine B, et al. Effect of protective filters on fire fighter respiratory health during simulated bushfire smoke exposure. Am J Ind Med 2006; 49: 740–750. [DOI] [PubMed] [Google Scholar]
  • 85.Triebig G, Werner P, Zimmer H. A field study to determine the effectiveness of several respiratory protection masks on the styrene exposure during lamination activities. Ind Health 2009; 47: 145–154. [DOI] [PubMed] [Google Scholar]
  • 86.Nakayama S, Nishide T, Horike T, et al. Evaluation of the efficiency of respiratory protective equipment based on the biological monitoring of styrene in fibreglass reinforced plastics industries. J Occup Health 2004; 46: 132–140. [DOI] [PubMed] [Google Scholar]
  • 87.Lof A, Brohede C, Gullstrand E, et al. The effectiveness of respirators measured during styrene exposure in a plastic boat factory. Int Arch Occup Environ Health 1993; 65: 29–34. [DOI] [PubMed] [Google Scholar]
  • 88.Janssen L, Bidwell J, Cuta K, et al. Workplace performance of a hood-style supplied-air respirator. J Occup Environ Hyg 2008; 5: 438–443. [DOI] [PubMed] [Google Scholar]
  • 89.Renstrom A, Karlsson AS, Tovey E. Nasal air sampling used for the assessment of occupational allergen exposure and the efficacy of respiratory protection. Clin Exp Allergy 2002; 32: 1769–1775. [DOI] [PubMed] [Google Scholar]
  • 90.Pickrell JA, Heber AJ, Murphy JP, et al. Total and respirable dust in swine confinement buildings: the benefit of respiratory protective masks and effect of recirculated air. Vet Hum Toxicol 1995; 37: 430–435. [PubMed] [Google Scholar]
  • 91.Brisman J, Jarvholm B, Lillienberg L. Exposure-response relations for self reported asthma and rhinitis in bakers. Occup Environ Med 2000; 57: 335–340. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 92.Renstrom A, Mattsson ML, Blidberg K, et al. Nasal air sampling for measuring inhaled wheat allergen in bakeries with and without facemask use. J Occup Environ Med 2006; 48: 948–954. [DOI] [PubMed] [Google Scholar]
  • 93.Dharmarajan V, Lingg RD, Myer HE. Evaluation of organic-vapor respirator cartridge efficiency for hexamethylene diisocyanate vapor in the presence of organic solvents. Appl Occup Environ Hyg 2001; 16: 397–404. [DOI] [PubMed] [Google Scholar]
  • 94.Bolsover J, Rajan-Sithamparanadarajah B, Vaughan N. Workplace protection of air-fed visors used in paint spraying operations. Ann Occup Hyg 2006; 50: 219–229. [DOI] [PubMed] [Google Scholar]
  • 95.The Royal College of General Practitioners. The Development and Implementation of Clinical Guidelines. Report of the Clinical Guidelines Working Group. London, RCGP, 1995. [Google Scholar]
  • 96.Atkins D, Best D, Briss PA, et al. Grading quality of evidence and strength of recommendations. BMJ 2004; 328: 1490. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from European Respiratory Review are provided here courtesy of European Respiratory Society

RESOURCES